A COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF FIDAXOMICIN FOR TREATING CLOSTRIDIUM DIFFICILE PATIENTS IN GERMANY

被引:1
|
作者
Watt, M. [1 ]
McCrea, C. [2 ]
Johal, S. [3 ]
Posnett, J. [2 ]
Nazir, J. [1 ]
机构
[1] Astellas, Chertsey, Surrey, England
[2] Heron Commercializat, London, England
[3] Parexel Int, London, England
关键词
D O I
10.1016/j.jval.2015.03.1357
中图分类号
F [经济];
学科分类号
02 ;
摘要
PIN33
引用
收藏
页码:A233 / A233
页数:1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF UMEC/VI FOR THE TREATMENT OF COPD PATIENTS IN COLOMBIA
    Gamboa Garay, O. A.
    Medina Torres, Y. A.
    Gamboa Garay, C. A.
    Bastidas Goyes, A. R.
    Dieleman, S.
    VALUE IN HEALTH, 2017, 20 (05) : A201 - A201
  • [42] A BUDGET IMPACT ANALYSIS OF FIDAXOMICIN FOR THE MANAGEMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION IN THE UNITED STATES
    Jiang, Y.
    Obi, E. N.
    Sears, P. S.
    Sarpong, E.
    VALUE IN HEALTH, 2020, 23 : S144 - S145
  • [43] Cost-effectiveness of Competing Strategies for Management of Recurrent Clostridium difficile Infection: A Decision Analysis
    Konijeti, Gauree G.
    Sauk, Jenny
    Shrime, Mark G.
    Gupta, Meera
    Ananthakrishnan, Ashwin N.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (11) : 1507 - 1514
  • [44] On decision rules, cost-effectiveness, and budget impact
    Luis Pinto, Jose
    Antonio Sacristan, Jose
    Antonanzas, Fernando
    GACETA SANITARIA, 2008, 22 (06) : 585 - 589
  • [45] Bariatric Surgery: Cost-Effectiveness and Budget Impact
    Terranova, Lorenzo
    Busetto, Luca
    Vestri, Annarita
    Zappa, Marco Antonio
    OBESITY SURGERY, 2012, 22 (04) : 646 - 653
  • [46] Bariatric Surgery: Cost-Effectiveness and Budget Impact
    Lorenzo Terranova
    Luca Busetto
    Annarita Vestri
    Marco Antonio Zappa
    Obesity Surgery, 2012, 22 : 646 - 653
  • [47] Is Fidaxomicin the Drug of Choice for Treating Clostridium difficile-Associated Diarrhea in Patients With Cancer? Reply
    Cornely, Oliver A.
    Miller, Mark A.
    Fantin, Bruno R.
    Mullane, Kathleen M.
    Kean, Yin
    Gorbach, Sherwood L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4379 - 4379
  • [48] Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease
    You, Joyce H. S.
    Jiang, Xinchan
    Lee, Wally H.
    Chan, Paul K. S.
    Ng, Siew C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (09) : 1515 - 1523
  • [49] Safety and Efficacy of Fidaxomicin in Patients With Clostridium Difficile Infection
    Donnelley, Monica A.
    Duby, Jeremiah J.
    Cocanour, Christine S.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 75 - 79
  • [50] Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors
    Cortesi, Paolo Angelo
    Castaman, Giancarlo
    Trifiro, Gianluca
    Creazzola, Simona Serao
    Improta, Giovanni
    Mazzaglia, Giampiero
    Molinari, Angelo Claudio
    Mantovani, Lorenzo Giovanni
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (02) : 216 - 228